Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Would you anticoagulate an SMV thrombosis caused by malignant obstruction in the setting of metastatic colorectal cancer?
For what duration and is there a preferred anticoagulation agent?
Related Questions
Would you recommend indefinite anticoagulation in any scenario of a provoked clot?
How long do you anticoagulate for cirrhosis patients who have portal vein thrombosis extending to the mesenteric veins?
How do you manage hemophilia A carriers with no history of bleeding complications but with mildly low factor VIII activity (6-40%)?
Do you use direct oral anticoagulants to treat port-a-cath related VTE in patients with an active malignancy?
Would you consider caplacizumab in a pregnant patient with iTTP?
Does PT/PTT elevation due to severe vitamin K deficiency protect against thrombosis?
How long post operatively do you wait before transitioning from parenteral anticoagulation to oral anticoagulants after pulmonary thromboendarterectomy for CTEPH?
How long would you anticoagulate for PE developed after air travel in a woman on an estrogen containing vaginal ring for contraception?
How do you start and manage therapeutic SC heparin for acute thrombosis in pregnancy as the patient approaches delivery?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?